OPUM Technologies

Company Overview

OPUM Technologies is a digital health company reinventing musculoskeletal rehabilitation through its patented Digital Knee® platform — a wearable sensor system paired with a HIPAA-compliant patient app and clinician portal. The technology, built on OPUM's proprietary Dynamic Goniometry approach, continuously measures joint movement during real activity rather than relying on the manual, static assessments and self-reported compliance that have historically defined orthopedic recovery. This lets clinicians verify rehab adherence between visits, and lets payers see documented proof that patients have completed required conservative-care protocols — a growing requirement under Medicare and private insurance reimbursement rules. The company targets three large, underserved segments of knee care: ACL and meniscus repair, total knee replacement, and osteoarthritis. Capital from this raise is earmarked for sales and marketing expansion, continued platform R&D, partial debt repayment, and general working capital. OPUM's edge comes from its FDA-registered hardware, a five-patent-family IP portfolio, and a business model that layers device sales with recurring SaaS and remote-monitoring reimbursement revenue — positioning the company for a longer-term outcome through acquisition by a strategic healthcare or medtech acquirer, or a public listing.

Investment Snapshot

Why Invest

• Patented Digital Knee® platform — FDA-registered hardware paired with a HIPAA-compliant app and clinician portal, already commercializing in the U.S.
• Five consolidated patent families covering 16 inventions, protecting core sensor hardware, AI algorithms, and reimbursement-enabling software
• Diversified revenue model layering device sales with high-margin, recurring SaaS and Remote Therapeutic Monitoring reimbursement revenue
• Experienced leadership team, including a CEO with a prior healthcare company exit

Market Opportunity

Fewer than half of U.S. knee-surgery patients complete their prescribed rehab today, and clinicians have historically had no objective way to verify progress between visits. Rising procedure volumes, tightening payer documentation requirements — including Medicare's conservative-care mandate ahead of knee replacement — and a broader shift toward remote patient monitoring are converging to drive demand for platforms like OPUM's.

Team

David Smith

CEO

30+ years building and scaling companies. Previously founding CEO of Tenaxis Medical, a surgical sealant business acquired in a 2014 transaction.

James "Jamie" Henderson

Executive Chairman

40+ years in financial advisory across mining, medical devices, aged care, clean energy, and natural resources. Executive Chairman of Transocean Group; previously National Chairman of Sothertons Chartered Accountants (WA). Chartered Accountant.

Alexandra Wilson

VP Finance & Administration

Background in advertising and marketing (Ford, Vodafone, Discovery Channel, Eurosport, including Winter Olympics campaigns); has led OPUM through a period of financial restructuring and repositioning for commercial scale.

Cody Wilson

Product Manager

5+ years in orthopedic and digital health product roles at Smith+Nephew, Salix Pharmaceuticals, and IQVIA, with a track record in surgeon engagement and clinical workflow design.